About Alpex Pharma
Alpex Pharma is a company based in Mezzovico-vira (Switzerland) founded in 2000. Alpex Pharma has raised $9.05 million across 1 funding round from investors including BB Biotech Ventures and Signet Healthcare Partners. Alpex Pharma offers products and services including Pharmaceutical Products, Nutraceuticals, and Formulation Development. Alpex Pharma operates in a competitive market with competitors including Kapiva, Jubilant Life Sciences, Recipharm, ChromaDex and Akums, among others.
- Total Equity Funding$9.05M (USD)
in 1 rounds
- Latest Funding Round$9.05M (USD), Series B
Aug 2007
- InvestorsBB Biotech Ventures
& 1 more
Products & Services of Alpex Pharma
Alpex Pharma offers a comprehensive portfolio of products and services, including Pharmaceutical Products, Nutraceuticals, and Formulation Development.
Innovative drugs for therapeutic areas like pain management.
Nutritional products supporting wellness and disease prevention.
Services for developing and scaling pharmaceutical formulations.
Funding Insights of Alpex Pharma
Alpex Pharma has successfully raised a total of $9.05M through 1 strategic funding round. The most recent funding activity was a Series B round of $9.05 million completed in August 2007. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $9.05M
- Total Rounds 1
- Last Round Series B — $9.05M
- First Round $9.05M
(Aug 2007)
- Investors Count 2
All 1 funding rounds of Alpex Pharma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2007 | $9.05M | Series B | – | BB Biotech Ventures |
2 investors in total: 2 institutional.
Investors in Alpex Pharma
Alpex Pharma has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include BB Biotech Ventures and Signet Healthcare Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
- | – | bbbiotechventures.com | - | |
PE firm investing in North America and Europe | – | signethealthcarepartners.com | New York, United States |
Investor details for Alpex Pharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Alpex Pharma
1 people are tracked at Alpex Pharma (1 in leadership).
| Name | Role | Group |
|---|---|---|
Shahbaz Ardalan | CEO & MD | Leadership |
Complete people profiles for Alpex Pharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Alpex Pharma
2 dated milestones of Alpex Pharma across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Alpex Pharma is founded.
- Funding First funding round of $9.0M.
Competitors of Alpex Pharma
Alpex Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Kapiva, Jubilant Life Sciences, Recipharm, ChromaDex and Akums, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| kapiva.in | 2016 | Bengaluru, India | $77.85M | 492 | Ayurvedic healthcare and nutritional products are provided by Kapiva. | |
| jubl.com | 1978 | Noida, India | – | – | Company offering a suite of R&D and manufacturing services for small molecules and generics | |
| recipharm.com | 1995 | Jordbro, Sweden | – | 1,083 | Pharmaceutical development and manufacturing services are offered contractually. | |
| chromadex.com | 1999 | Irvine, United States | $3.39M | 228 | Nutritional ingredients for health and wellness are developed. | |
| akums.in | 2004 | Delhi, India | $70M | 395 | CDMO focusing on spectrum of dosage forms and therapeutic segments | |
| unither-pharma.com | 1993 | Paris, France | – | – | Contract development and manufacturing organization for proprietary and generic drugs | |
| neclife.com | 1995 | Chandigarh, India | $46.85M | 175 | Cephalosporin APIs and generic formulations are manufactured. | |
| corerxpharma.com | 2006 | Clearwater, United States | $15M | – | CDMO with a focus on early phase drug product development | |
| labomar.com | 1998 | Treviso, Italy | $6.9M | – | Dietary supplements, diet foods, health products, and medical devices | |
| windlas.com | 2001 | Gurugram, India | $12.96M | 1,264 | Biopharma regulatory affairs, quality control, and strategy services are provided. |
Detailed competitors of Alpex Pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Alpex Pharma
The website of Alpex Pharma (alpex.com) receives about 4.1K visits a month.
- Monthly visits4.1K
▼ 17% vs previous month
Latest news on Alpex Pharma
Complete news archive for Alpex Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Alpex Pharma
10 companies that operate in the same segment as Alpex Pharma (Nutraceutical & Food-as-Medicine Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Ayurvedic healthcare and nutritional products are provided by Kapiva. | 2016 | Bengaluru, Karnataka, India | USD 77.85 M | USD 27.35 M | 362 | |
Plant-based frozen meals are delivered via weekly subscriptions. | 2016 | London, England, United Kingdom | USD 69.9 M | USD 12.54 M | 146 | |
Therapies for metabolic health in chronic disease patients are provided. | 2014 | San Francisco, California, United States | USD 401.78 M | – | – | |
Nutritional supplements for multiple health ailments are developed. | 2005 | Mumbai, Maharashtra, India | USD 1.55 M | – | – | |
Personalized gut health solutions are provided by ZOE. | 2017 | New Castle, Pennsylvania, United States | USD 80.12 M | – | – | |
Machine learning-based bioinformatics solutions for health insights are provided. | 2016 | Los Alamos, New Mexico, United States | USD 301.57 M | – | – | |
Cellular health supplements for metabolic repair are developed and manufactured. | 2014 | New York, New York, United States | USD 66.1 M | – | – | |
Nutritional food and health supplements are provided by OZiva. | 2010 | Mumbai, Maharashtra, India | USD 17.32 M | USD 23.98 M | – | |
Low-carb products for weight loss are provided by Atkins. | 1960 | Denver, Colorado, United States | USD 15 M | – | – | |
Synbiotic supplements and fermented products for gut health are provided. | 2021 | Mumbai, Maharashtra, India | USD 20.02 M | USD 5.14 M | 88 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Alpex Pharma
Alpex Pharma was founded in 2000 and raised its 1st funding round 7 years after it was founded.
Alpex Pharma is headquartered in Mezzovico-vira, Switzerland. It is registered at Mezzovico-vira, Ticino, Switzerland.
Shahbaz Ardalan is the current CEO of Alpex Pharma.
Alpex Pharma is a funded company, having raised a total of $9.05M across 1 funding round to date. The company's 1st funding round was a Series B of $9.05M, raised on Aug 2007.
Alpex Pharma was founded in 2000 and is based in Mezzovico Vira, Switzerland. Operations focus on the pharmaceutical sector as a contract research organization. Services encompass contract manufacturing, formulation development, nutritional supplements, prescription products, and drug delivery solutions. RD projects are also conducted for orodispersible tablet versions of existing drugs. Leadership is provided by CEO MD Shahbaz Ardalan.
Alpex Pharma's top competitors include Kapiva, Jubilant Life Sciences and Akums.
Alpex Pharma offers Pharmaceutical Products, Nutraceuticals, and Formulation Development.
Alpex Pharma has 2 investors. Key investors include BB Biotech Ventures, and Signet Healthcare Partners.
Alpex Pharma operates through Alpex Pharma Sa.